• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病与血栓形成共病:来自患者和动物模型的证据日益增多。

Alzheimer's Disease-Thrombosis Comorbidity: A Growing Body of Evidence from Patients and Animal Models.

作者信息

Koch-Paszkowski Joanna, Sennett Christopher, Pula Giordano

机构信息

Biomedical Institute of Multimorbidity, Centre for Biomedicine, Hull York Medical School, University of Hull, Hull HU6 7RX, UK.

出版信息

Cells. 2025 Jul 12;14(14):1069. doi: 10.3390/cells14141069.

DOI:10.3390/cells14141069
PMID:40710322
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12293712/
Abstract

BACKGROUND/OBJECTIVES: A growing body of evidence is amassing in the literature suggesting a correlation between Alzheimer's disease (AD) and thrombotic vascular complications, which led to the suggestive hypothesis that thrombosis may contribute to AD onset and progression by damaging the neurovasculature and reducing the cerebral blood flow. In turn, low cerebral blood flow is likely to contribute to neurodegeneration by reducing nutrient and oxygen supply and impairing toxic metabolite removal from the brain tissue.

METHODS

We searched the literature for studies in animal models of AD or patients diagnosed with the disease that reported circulating markers of platelet hyperactivity or hypercoagulation, or histological evidence of brain vascular thrombosis.

RESULTS

Platelet hyperactivity and hypercoagulability have been described in multiple animal models of AD, and histological evidence of neurovascular thrombosis has also been reported. Similarly, clinical studies on patients with AD showed circulating markers of platelet hyperactivity and hypercoagulation, or histological evidence of neurovascular thrombosis collected from post-mortem brain tissue samples.

CONCLUSIONS

Taken together, a convincing picture is emerging that suggests a strong correlation between systemic or neurovascular thrombosis and AD. Nonetheless, a mechanistic role for haemostasis dysregulation and neurovascular damage in the onset or the progression of AD remains to be proven. Future research should focus on this important question in order to clarify the mechanisms underlying AD and identify a treatment for this disease.

摘要

背景/目的:文献中积累的证据越来越多,表明阿尔茨海默病(AD)与血栓性血管并发症之间存在关联,这引发了一个推测性假设,即血栓形成可能通过损害神经血管系统和减少脑血流量,从而导致AD的发生和进展。反过来,低脑血流量可能通过减少营养物质和氧气供应以及损害从脑组织中清除有毒代谢产物,进而导致神经退行性变。

方法

我们在文献中搜索了关于AD动物模型或已确诊患者的研究,这些研究报告了血小板活性亢进或高凝状态的循环标志物,或脑血管血栓形成的组织学证据。

结果

在多种AD动物模型中均描述了血小板活性亢进和高凝状态,并且也报道了神经血管血栓形成的组织学证据。同样,针对AD患者的临床研究显示,存在血小板活性亢进和高凝状态的循环标志物,或从尸检脑组织样本中收集到的神经血管血栓形成的组织学证据。

结论

综上所述,一个令人信服的情况正在显现,表明全身或神经血管血栓形成与AD之间存在密切关联。尽管如此,止血功能失调和神经血管损伤在AD发病或进展中的机制作用仍有待证实。未来的研究应关注这个重要问题,以阐明AD的潜在机制并确定该疾病的治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef0a/12293712/8b8736adc5b5/cells-14-01069-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef0a/12293712/8b8736adc5b5/cells-14-01069-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef0a/12293712/8b8736adc5b5/cells-14-01069-g001.jpg

相似文献

1
Alzheimer's Disease-Thrombosis Comorbidity: A Growing Body of Evidence from Patients and Animal Models.阿尔茨海默病与血栓形成共病:来自患者和动物模型的证据日益增多。
Cells. 2025 Jul 12;14(14):1069. doi: 10.3390/cells14141069.
2
A Novel Design of a Portable Birdcage via Meander Line Antenna (MLA) to Lower Beta Amyloid (Aβ) in Alzheimer's Disease.一种通过曲折线天线(MLA)设计的便携式鸟笼,用于降低阿尔茨海默病中的β淀粉样蛋白(Aβ)。
IEEE J Transl Eng Health Med. 2025 Apr 10;13:158-173. doi: 10.1109/JTEHM.2025.3559693. eCollection 2025.
3
The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease.多奈哌齐、卡巴拉汀、加兰他敏和美金刚用于治疗阿尔茨海默病的临床疗效及成本效益
Health Technol Assess. 2006 Jan;10(1):iii-iv, ix-xi, 1-160. doi: 10.3310/hta10010.
4
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
5
Pharmacological interventions for apathy in Alzheimer's disease.阿尔茨海默病中淡漠症状的药物干预措施。
Cochrane Database Syst Rev. 2018 May 4;5(5):CD012197. doi: 10.1002/14651858.CD012197.pub2.
6
Recent advances in the detection and management of motor dysfunction in Alzheimer's disease.阿尔茨海默病运动功能障碍检测与管理的最新进展
Psychiatriki. 2025 May 14. doi: 10.22365/jpsych.2025.012.
7
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.戈谢病酶替代疗法的临床疗效和成本效益:一项系统评价。
Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240.
8
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
9
Pharmacotherapies for sleep disturbances in Alzheimer's disease.用于治疗阿尔茨海默病睡眠障碍的药物疗法。
Cochrane Database Syst Rev. 2014 Mar 21(3):CD009178. doi: 10.1002/14651858.CD009178.pub2.
10
Vitamin E for Alzheimer's dementia and mild cognitive impairment.维生素E用于治疗阿尔茨海默病性痴呆和轻度认知障碍。
Cochrane Database Syst Rev. 2017 Jan 27;1(1):CD002854. doi: 10.1002/14651858.CD002854.pub4.

本文引用的文献

1
The effects of coagulation factors on the risk of Alzheimer's disease: A Mendelian randomization study.凝血因子对阿尔茨海默病风险的影响:一项孟德尔随机化研究。
J Alzheimers Dis Rep. 2025 Mar 21;9:25424823251327674. doi: 10.1177/25424823251327674. eCollection 2025 Jan-Dec.
2
Reduced platelet activation and thrombus formation in male transgenic model mice of Alzheimer's disease suggests early sex-specific differences in platelet pathophysiology.阿尔茨海默病转基因雄性模型小鼠血小板活化和血栓形成减少提示血小板病理生理学的早期性别特异性差异。
Mol Cell Neurosci. 2024 Sep;130:103952. doi: 10.1016/j.mcn.2024.103952. Epub 2024 Jul 11.
3
Human platelets release amyloid peptides β and β in response to haemostatic, immune, and hypoxic stimuli.
人类血小板在止血、免疫和缺氧刺激下会释放β淀粉样肽和β淀粉样肽。
Res Pract Thromb Haemost. 2023 May;7(4):100154. doi: 10.1016/j.rpth.2023.100154.
4
Meta-analysis and systematic review of peripheral platelet-associated biomarkers to explore the pathophysiology of alzheimer's disease.外周血小板相关生物标志物的荟萃分析和系统评价,以探索阿尔茨海默病的病理生理学。
BMC Neurol. 2023 Feb 11;23(1):66. doi: 10.1186/s12883-023-03099-5.
5
No difference in cerebral perfusion between the wild-type and the 5XFAD mouse model of Alzheimer's disease.阿尔茨海默病的野生型和 5XFAD 小鼠模型之间的脑灌注无差异。
Sci Rep. 2022 Dec 22;12(1):22174. doi: 10.1038/s41598-022-26713-x.
6
Vascular contributions to Alzheimer's disease.血管对阿尔茨海默病的影响。
Transl Res. 2023 Apr;254:41-53. doi: 10.1016/j.trsl.2022.12.003. Epub 2022 Dec 15.
7
Redefining oxidative stress in Alzheimer's disease: Targeting platelet reactive oxygen species for novel therapeutic options.重新定义阿尔茨海默病中的氧化应激:针对血小板活性氧以寻求新的治疗选择。
Life Sci. 2022 Oct 1;306:120855. doi: 10.1016/j.lfs.2022.120855. Epub 2022 Aug 1.
8
Platelet Function Is Associated With Dementia Risk in the Framingham Heart Study.血小板功能与弗雷明汉心脏研究中的痴呆风险相关。
J Am Heart Assoc. 2022 May 3;11(9):e023918. doi: 10.1161/JAHA.121.023918. Epub 2022 Apr 26.
9
Systematic Phenotyping and Characterization of the 3xTg-AD Mouse Model of Alzheimer's Disease.阿尔茨海默病3xTg-AD小鼠模型的系统表型分析与特征描述
Front Neurosci. 2022 Jan 24;15:785276. doi: 10.3389/fnins.2021.785276. eCollection 2021.
10
Impact of Amyloid-β on Platelet Mitochondrial Function and Platelet-Mediated Amyloid Aggregation in Alzheimer's Disease.淀粉样蛋白-β对阿尔茨海默病血小板线粒体功能和血小板介导的淀粉样蛋白聚集的影响。
Int J Mol Sci. 2021 Sep 6;22(17):9633. doi: 10.3390/ijms22179633.